Iván Márquez‐Rodas
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cutaneous Melanoma Detection and Management
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 72
- Cancer Immunotherapy and Biomarkers 39
- CAR-T cell therapy research 32
- Cutaneous Melanoma Detection and Management 19
-
- Melanoma and MAPK Pathways 31
- Co-authors
- Vanna Chiarion‐Sileni (14 shared papers)Dirk Schadendorf (14 shared papers)James Larkin (19 shared papers)David Hogg (6 shared papers)Michael Smylie (10 shared papers)Piotr Rutkowski (11 shared papers)F. Stephen Hodi (12 shared papers)Reinhard Dummer (9 shared papers)
- Journals
- Annals of Oncology (27 papers)Journal of Clinical Oncology (19 papers)Clinical & Translational Oncology (16 papers)Breast Cancer Research and Treatment (3 papers)Regulatory Peptides (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Iván Márquez‐Rodas
111 papers receiving 4.1k citations
Iván Márquez‐Rodas's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 2.6k
- Immunology 1.0k
- Cancer Research 307
- Pulmonary and Respiratory Medicine 608
- Genetics 168
Countries citing papers authored by Iván Márquez‐Rodas
This map shows the geographic impact of Iván Márquez‐Rodas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Márquez‐Rodas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Márquez‐Rodas more than expected).
Fields of papers citing papers by Iván Márquez‐Rodas
This network shows the impact of papers produced by Iván Márquez‐Rodas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Márquez‐Rodas. The network helps show where Iván Márquez‐Rodas may publish in the future.
Co-authors
The 25 scholars most cited alongside Iván Márquez‐Rodas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial Hit paper breakdown → | 2018 | 1033 |
| 2 | Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Hit paper breakdown → | 2017 | 490 |
| 3 | 2019 | 329 | |
| 4 | 2019 | 253 | |
| 5 | 2018 | 200 | |
| 6 | 2017 | 127 | |
| 7 | 2005 | 104 | |
| 8 | 2019 | 104 | |
| 9 | 2021 | 103 | |
| 10 | 2015 | 85 | |
| 11 | 2012 | 71 | |
| 12 | 2019 | 67 | |
| 13 | 2018 | 64 | |
| 14 | 2015 | 60 | |
| 15 | 2016 | 55 | |
| 16 | 2022 | 54 | |
| 17 | 2018 | 53 | |
| 18 | 2020 | 42 | |
| 19 | 2014 | 42 | |
| 20 | 2014 | 41 |
About Iván Márquez‐Rodas
Iván Márquez‐Rodas is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 121 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (39 papers), CAR-T cell therapy research (32 papers), Melanoma and MAPK Pathways (31 papers), Cutaneous Melanoma Detection and Management (19 papers), Immunotherapy and Immune Responses (13 papers), BRCA gene mutations in cancer (8 papers), Cancer-related molecular mechanisms research (5 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (2.6k citations), Immunology (1.0k citations), Cancer Research (307 citations), Pulmonary and Respiratory Medicine (608 citations) and Genetics (168 citations). Iván Márquez‐Rodas has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Vanna Chiarion‐Sileni, Dirk Schadendorf, James Larkin, David Hogg, Michael Smylie, Piotr Rutkowski, F. Stephen Hodi, Reinhard Dummer, René González and Jedd D. Wolchok. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Clinical & Translational Oncology, Breast Cancer Research and Treatment and Regulatory Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.